Publications COVID, LONG COVID

Loo R L, Lodge S, Kimhofer T1, Bong S H 1, Begum S, Whiley L, Gray N, Lindon J C, Nitschke P, Lawler N G, Schäfer H, Spraul M, Richards T, Nicholson J K, Holmes E Quantitative In-Vitro Diagnostic NMR Spectroscopy for Lipoprotein and Metabolite Measurements in Plasma and Serum: Recommendations for Analytical Artifact Minimization with Special Reference to COVID-19/SARS-CoV-2 Samples J Proteome Res. 2020 Nov 6;19(11):4428-4441. DOI: 10.1021/acs.jproteome.0c00537

Lodge S, Nitschke P, Kimhofer T, Coudert J D, Begum S, Bong S H, Richards T, Edgar D, Raby J, Spraul M, Schaefer H, Lindon J C, Loo R, Holmes E,  Nicholson J K, NMR Spectroscopic Windows on the Systemic Effects of SARS-CoV‑2 Infection on Plasma Lipoproteins and Metabolites in Relation to Circulating Cytokines DOI: 10.1021/acs.jproteome.0c00876

Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, Loo 2R L, Begum S, Boughton B, Yang R,  Morillon A, Chin S, Hall D, Ryan M, Bong S H, Gay M, Edgar D W, Lindon J C, Richards T, Yeap B B, Pettersson S, Spraul M, Schaefer H, Lawler N G, Gray N, Whiley L, Nicholson J K Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome J Proteome Res. 2021 Jun 4;20(6):3315-3329. DOI: 10.1021/acs.jproteome.1c00224.

Nitschke P, Lodge S, Hall D, Schaefer H, Spraul M, Embade N, Millet O, Holmes E, Wist J and Nicholson J K Direct low field J-edited diffusional proton NMR spectroscopic measurement of COVID-19 inflammatory biomarkers in human serum Analyst, 2022, 147, 4213, DOI: 10.1039/d2an01097f

Masuda R, Lodge S, Whiley L, Gray N, Lawler N, Nitschke P, Bong S H, Kimhofer T, Leng Loo R, Boughton B, Zeng A X, Hall D, Schaefer H, Spraul M, Dwivedi G, Yeap B B, Diercks D, Bernardo-Seisdedos G, Mato J M, Lindon J C, Holmes H, Millet O, Wist J and Nicholson J K Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in n‑Dimensions (SHY‑n): Identification of Potential Cardiovascular Risk Biomarkers Related to SARS-CoV‑2 Infection Anal. Chem. 2022, 94, 4426−443